Skip to main content
. 2014 Nov 19;57(23):9995–10012. doi: 10.1021/jm5012337

Table 2. Effects of 2 on the Tumor Growth of MDA-MB-231 Mammary Carcinoma in NOD.CB17-Prkdc scid/J Mice.

treatment group primary tumor (mm3)
controls 473.47 ± 45.44
compound 2 (5 mg/kg/eoda × 14) 59.58 ± 8.66
a

eod = every other day. Tumor measured on day 28, after the 14th dose.